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Bronchogenic carcinomaAbstract One of the main indications for therapeutic endoscopic treatment is palliation of
advanced cancerous lesions. The main purpose is the relief of dyspnea due to central airway
obstruction, and the pre-operative evaluation to conﬁrm that the lung beyond the obstruction is via-
ble and that dyspnea is effectively related to the obstruction (Wahidi et al., 2007) [1].
This study was carried out in the Chest Department at Tanta and Zagazig University Hospitals
from May 2012 to December 2012 on 20 cases with endobronchial tumor present in the proximal
main or lobar bronchi and proved to be Non-Small Cell Lung Carcinoma (NSCLC) by histopathol-
ogical examination of stage IIIA or IIIB according to the AJCC staging (Rami-Porta et al. (2011)
[2]).
This study aimed to compare the clinical, functional and radiological outcome of electrocauteri-
zation and argon plasma coagulation as a palliative treatment for bronchogenic carcinoma.
Patients were classiﬁed into 2 groups: Group 1: Included 10 patients and they were managed by
palliative electrocautery. Group 2: Included 10 patients and they were managed by palliative argon
plasma coagulation. The number of therapy sessions was ranged from one to four sessions (15–
40 min each), with one week interval between each session.
After application of bronchoscopic electrocautery on patients in group I, and argon plasma coag-
ulation on patients in group II, there was more signiﬁcant control of hemoptysis in group I com-
pared to group II. Both groups showed a signiﬁcant improvement in ventilatory function tests
and arterial oxygen tension PaO2 before and after bronchoscopic intervention. Also, there was
no signiﬁcant difference between the 2 groups as regards post treatment complications.d.
Table 1 Comparison between the
Symptoms Group (I): number of
having symptoms, no
Before treatment
Cough 10/10 (100%)
Hemoptysis 9/10 (90%)
Dyspnea 10/10 (100%)
Fever 7/10 (70%)
* p< 0.05.
244 A.A. Farhat et al.It was concluded that, therapeutic bronchoscopic intervention either by electrocautery or argon
plasma coagulation is a safe and effective method for palliative management of patients with central
malignant airway obstruction.
ª 2014 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V. All rights reserved.Introduction
Endobronchial electrosurgery is used to remove endobronchial
lesions in the trachea and bronchial tree, using either a rigid or
a ﬂexible bronchoscope. The thermal property of electric cur-
rent is used to destroy tissue or coagulate bleeding sites. Many
terms are used to describe the use of heat for tissue destruction
as: electrosurgery, electrocautery, electrotherapy and surgical
diathermy. We speciﬁcally use the term electrocautery (EC)
to describe the electrosurgical effect that requires contact
between probe and tissue for the conduction of electric current
which ionizes air resulting in tissue destruction or hemostasis
or both [3].
Argon plasma coagulation (APC) is a relatively
recent electrosurgical method whereby there is argon
gas ionization by an electric current to create a non-
contact, homogeneous ‘‘bridge’’ for tissue coagulation
or ablation [4,5].
The aim of the study is to compare between the two inter-
ventions (electrocauterization and argon plasma coagulation)
as a palliative treatment for bronchogenic carcinoma by both
clinical assessment and investigations including pulmonary
function tests and radiological ﬁndings.
Patients and methods
This study was carried out in the Chest Departments at Tanta
and Zagazig University Hospitals from May 2012 to Decem-
ber 2012 on 20 cases. This study was approved by the ethics
committee, Tanta Faculty of Medicine.
Inclusion criteria
To be eligible for the study, patients had to have:
 Endobronchial tumor in which its main component is end-
oluminal and present in the proximal main or lobar bronchi
and proved to be Non-Small Cell Lung Carcinoma
(NSCLC) by histopathological examination of stage IIIA
or IIIB according to the AJCC staging [2].2 studied groups according to sy
improved patients/patients
. (%)
1 week after
6/10 (60%)
5/10 (50%)
6/10 (60%)
6/10 (60%) In good general health without clinically signiﬁcant medical
history.
 No prior chemotherapy or radiotherapy.
Exclusion criteria
 Patients with respiratory or other organ failure.
 Patients with bleeding disorders.
 Patients with past history of allergic disorders to anesthetic
drugs.
 Patients with grades I, II, IV of bronchogenic carcinoma.
Included patients were classiﬁed into 2 groups:
Group 1: Included 10 patients and they were managed by
palliative electrocautery.
Group 2: Included 10 patients and they were managed by
palliative argon plasma coagulation.
The number of therapy sessions was ranged from one to
four sessions (15–40 min each), with one week interval between
each session.
Preoperative fasting
Solid food should be avoided for 8 h preoperatively to allow
sufﬁcient time for gastric emptying. But liquid ingestion could
be allowed up to 2 h preoperatively [6].
Premedication
Regular cardiovascular medication including antihypertensive
drugs and respiratory medication should be continued until the
day of intervention. Also intravenous atropine 0.5 mg could be
given immediately prior to intervention [7].
Monitoring
Intraoperative monitoring including pulse, oxygen saturation,
electrocardiography, and intermittent noninvasive measure-
ment of blood pressure was done [7].mptoms before and after 1 week of bronchoscopic therapy.
Group (II): number of improved Patients/patients
having symptoms, no. (%)
P value
Before treatment 1 week after
10/10 (100%) 7/10 (70%) 0.085
8/10 (80%) 7/10 (70%) 0.048*
10/10 (100%) 7/10 (70%) 0.085
6/10 (60%) 5/10 (50%) 0.057
Table 2 Comparison between the 2 groups according to
ventilatory function tests before and after 1 week of broncho-
scopic therapy.
Ventilatory-function test Group (I) Group (II)
FEV1%, mean ± SD
Pre-treatment 45.9 ± 11.9 65.9 ± 7.01
1 week-after 60.5 ± 11.24 74.10 ± 6.52
P value 0.009* 0.003*
FVC%, mean ± SD
Pre-treatment 57.8 ± 10.83 72.4 ± 5.52
1 week-after 70 ± 8.62 79.10 ± 5.28
P value 0.002* 0.020*
* p< 0.05.
Table 3 Comparison between the 2 studied groups according
to (PaO2) before and after 1 week of bronchoscopic therapy.
PaO2 (mmHg) Group (I) Group (II)
Before treatment 68.9 ± 8.94 77.8 ± 6.04
1 week after 76.6 ± 7.61 83.5 ± 4.99
P value *0.005 *0.048
* p< 0.05.
Table 4 Comparison between the 2 groups according to post
treatment complications.
Complications no. (%) Group (I) Group (II) P value
No-complications 8 (80%) 9 (90%) 0.966
Hemoptysis 1 (10%) 1 (10%) 0.999
Pneumothorax 1 (10%) 0 (0%)
Esophagitis 0 (0%) 0 (0%)
Pneumonia 0 (0%) 0 (0%)
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For interventional ﬂexible bronchoscopy we used intravenous
anesthesia consisting of hypnotic ‘‘midazolam’’ and analgesia
‘‘fentanyl’’ [7].Figure 1 (a) and (b) show a case with right central mass associated with post obstructive pneumonia.
Figure 3 (a) and (b) show left upper mass.
Figure 4 Shows improvement after application of argon plasma
coagulation.
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Ventilatory support was done by a connector tube which has 3
ends, one connected to Endo Tracheal Tube and the second
connected to mechanical ventilator and the last end through
which Fibreoptic Bronchoscope was introduced [8].
Follow up
(1) Symptoms were recorded and scored before treatment
then one week after treatment using the Speiser symp-
tom score [9,10].
(2) Chest radiograph was done before and 1 week after
bronchoscopic session for evaluation of re-expansion
of atelectasis and prognosis of post obstruction
pneumonia.
(3) Pulmonary function tests and arterial blood gases were
done before and 1 week after bronchoscopic session
for prognosis of endo-bronchial obstruction.
Results
Statistical presentation and analysis of the present study were
conducted, using the mean, standard deviation and chi-square
test by SPSS (Statistical Package for Social Sciences) V.16.
After application of bronchoscopic electrocautery on the
included patients in group I, and argon plasma coagulation
on the included patients in group II our study results showed
that:
There was a signiﬁcantly higher difference as regards the
control of hemoptysis in group I compared to group II
(Table 1).
Both groups showed a signiﬁcant difference in the results of
ventilatory function tests for the included patients before and
after 1 week of bronchoscopic intervention (Table 2).
Both groups showed a signiﬁcant improvement in the
results of (PaO2) for the included patients before and 1 week
after bronchoscopic therapy (Table 3).
There was no signiﬁcant difference between the 2 studied
groups as regards the post treatment complications (Table 4).
In the following cases Fig. 1(a and b) and Fig. 2 show
improvement in a patient with the right central mass after
the application of electrocautery as the size of the mass was
reduced and post obstruction pneumonia was improved.Figure 2 Shows reduction in the size of the mass with improve-
ment in pneumonia after the application of electrocautery. Figure 5 Shows left lower mass with collapse.
Figure 6 Shows improvement after electrocautery.
Figure 7 Shows right lower mass with collapse.
Figure 8 Shows improvement after application of argon plasma
coagulation.
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left upper mass after application of argon plasma coagulation.Also Figs. 5 and 6 show improvement in post obstructive
collapse in a patient with the left lower lobe mass after appli-
cation of electrocautery.
Figs. 7 and 8 show the improvement in post obstructive col-
lapse and pneumonia in a patient with right basal mass after
application of argon plasma coagulation.
Discussion
When the airway obstruction is mainly endoluminal, endo-
scopic debulking provides immediate and safe relief of symp-
toms. This may be achieved by various techniques including
electrocautery and argon plasma coagulation [11].
It is clear from the available data that electrocautery and
argon plasma coagulation are effective and safe procedures
as palliative therapy for endobronchial obstruction [12].
In this study, there was improvement in clinical symptoms
as regards cough, dyspnea, hemoptysis and fever in the two
studied groups after bronchoscopic intervention with a signif-
icant control of hemoptysis in group I compared to group II.
Morice et al. (2001) demonstrated that there was an imme-
diate improvement in chest symptoms after tumor destruction
in all patients, with marked improvement in dyspnea immedi-
ately after endobronchial tumor debulking in 37 cases (53%)
[12]. Also, Kvale et al. (2003) showed immediate relief of dysp-
nea with electrocautery in 55–75% of patients [13], and Saw-
ang et al. (2006) reported that all the included patients
showed signiﬁcant improvement of symptoms including hem-
optysis [14].
In this study, there was signiﬁcant improvement in ventila-
tory function tests and arterial oxygen tension PaO2 before
and after bronchoscopic intervention in the two studied
groups.
Hosni et al. (2007) reported that improvement of pulmon-
ary function tests (PFT) in the included patients after applica-
tion of bronchoscopic electrocautery were
FVC+ 15.8%± 6.6 and FEV1 + 12.6%± 4.9 [15]. Also,
Rajif et al. (2012) reported that most of included patients with
central air way obstruction showed improvement after bron-
choscopic electrocautery as regards clinical manifestations
and pulmonary function tests [16].
In this study, only 1 patient suffered from pneumothorax in
group I and one patient in each group suffered from increased
hemoptysis.
Crosta et al. (2001) demonstrated that no dangerous com-
plications among the included patients have been observed
[10] and Bolliger et al. (2006) reported that no lethal complica-
tions related to the bronchoscopic electrocautery treatment
and no episodes of respiratory failure [11].Conﬂict of interest
There is no conﬂict of interest.
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